No products in the cart.
Gall Bladder & Pancreatic Cancer Antibodies
Pancreatic cancers are a rare diagnosed cancer in the United States, with about 2.8% of new cancer cases classified as pancreatic, contributing approx. 6.8% of cancer deaths yearly. As of 2011, there were approximately 44,000 people living with pancreatic cancer in the United States. Those diagnosed with pancreatic cancer have a 5 year survival rate of 6.7%. Over the last 10 years, the rate of new cancer cases has been stable while the death rate has risen 0.4% each year. Biocare Medical is proud to offer key pancreatic and gall bladder antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.
SEER Cancer Statistics Factsheets: Pancreas Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/pancreas.html